A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
167/179, 167/103
A61K 31/00 (2006.01) A61K 38/55 (2006.01)
Patent
CA 1328608
GLAUCOMA TREATMENT ABSTRACT A method and a composition for treating or reducing and/or controlling intraocular pressure comprising administering an effective amount of a renin inhibiting compound of the formula: Image wherein A is a substituent: W is CO or CHOH and U is CH2 or NR2 wherein R2 is hydrogen or loweralkyl; with the proviso that when W is CHOH then U is CH2; R1 is loweralkyl, cycloalkyl, benzyl, (alpha, alpha)-dimethylbenzyl, 4-hydroxybenzyl, 4-methoxybenzyl, halobenzyl, (1-naphthyl)methyl, (2-naphthyl)methyl, (4-imidazoyl)methyl, phenethyl, 1-benzyloxyethyl, phenoxy, thiophenoxy or anilino; R3 is loweralkyl, loweralkenyl, ((alkoxy)alkoxy)alkyl, carboxyalkyl, (thioalkoxy)alkyl, benzyl or heterocyclic ring substituted methyl; and R4 is a substituted amino group; or pharmaceutically acceptable salts or esters thereof. Also disclosed are compositions, methods and kits for treating glaucoma or reducing and/or controlling intraocular pressure wherein the renin inhibiting compound is administered in combination with a beta-adrenergic antagonist, a steroidal antiinflammatory agent or an angiotensin converting enzyme inhibiting compound.
579269
Crowley Steven R.
Plattner Jacob J.
Stein Herman H.
Abbott Laboratories
Goudreau Gage Dubuc
LandOfFree
Glaucoma treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Glaucoma treatment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glaucoma treatment will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1172923